Abramson Cancer Center is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.
Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.
Abramson Cancer Center has participated in 34 clinical trials with 15 currently active.
Therapeutic areas: Malignant Solid Neoplasm, Metastatic Breast Cancer, Lobular Breast Carcinoma.
Sponsors: Roswell Park Cancer Institute, University of California, San Francisco, Merck Sharp & Dohme LLC.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Pennsylvania · View every site in Philadelphia
Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Abramson Cancer Center has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Abramson Cancer Center has 34 clinical trials on record, with 15 currently active. Their work covers Malignant Solid Neoplasm, Metastatic Breast Cancer, Lobular Breast Carcinoma.
Abramson Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.